Comparing the Effects of Smoked and Oral Marijuana in Individuals With HIV/AIDS

Completed · Phase 1/Phase 2

Conditions studied: HIV Infections

In brief

Smoked marijuana (MJ) and dronabinol (also known as THC or by the trade name Marinol) are used to increase appetite, food intake, and weight in patients with HIV who experience unintended weight loss. This study will compare the effects of MJ and Marinol use in marijuana smokers who are HIV infected.

Key facts

Study ID

NCT00079560

Run by

National Institute on Drug Abuse (NIDA)

People needed

30

Starts

2001-12-01

Expected to finish

2005-08-01

Last updated by the study team

2017-01-11

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV infected
• Smoke marijuana
• Taking HIV medications

You may not qualify if…

• Naive marijuana smokers
• People with history of respiratory/pulmonary disease

Where it is running

• New York State Psychiatric Institute — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.